Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacogenetic Testing in the Clinical Setting: is Screening for TPMT Genotype a Cost-effective Treatment Strategy? - The First Prospective Randomized Controlled Trial Within the Dutch Health Care System.

NCT00521950 is registered in ClinicalTrials.gov with ZonMw: The Netherlands Organisation for Health Research and Development as lead sponsor.

NCT NCT00521950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00521950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacogenetic Testing in the Clinical Setting: is Screening for TPMT Genotype a Cost-effective Treatment Strategy? - The First Prospective Randomized Controlled Trial Within the Dutch Health Care System.
Lead sponsor
ZonMw: The Netherlands Organisation for Health Research and Development
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2007
Completion date
December 31, 2011
Enrollment
853 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, inflammatory bowel diseases, ulcerative colitis